Citigroup
TWST icon

Citigroup’s Twist Bioscience TWST Stock Holding History

Citigroup’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,600
Closed -$501K – 5786
2024
Q1 		$501K Buy
+14,600
New +$527K ﹤0.01% 3572

Other funds holding TWST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Stephens Investment Management Group
Stephens Investment Management Group Houston, Texas $9.29B AUM 41.16% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return

Citigroup's TWST Position: Q3 2026 in Review

Citigroup reduced its Twist Bioscience (TWST) stake by 28% in Q3 2026, selling an estimated $2.73M and leaving 55,562 shares worth $10.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1572.

Citigroup first reported a position in TWST in Q4 2018 and has held it in 32 quarters since. The position peaked at $21.9M in Q1 2026. 217 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • Citigroup held 55,562 shares of Twist Bioscience worth $10.7M as of Q3 2026.
  • Citigroup sold 22,064 Twist Bioscience shares in Q3 2026, an estimated $2.73M.
  • Twist Bioscience made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #1572 holding.
  • Citigroup first reported a position in Twist Bioscience in Q4 2018 and has held it in 32 quarters since.
  • Citigroup's Twist Bioscience position peaked at $21.9M in Q1 2026.
  • 217 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.